Life Science

Development of medicines and analysis methods, manufacturing of clinical trial materials and commercial manufacturing.

We can help you, wherever you are in the process.

Product development

  • Development of formulations for medicines and medical devices
  • Development of analytical methods
  • Stability studies

Manufacture of clinical trial materials

  • Project management and project planning
  • Manufacture of trial medicines and placebo
  • QP release
  • Randomising, labelling and packaging

Commercial manufacture

  • Upscaling to commercial level
  • Tech transfer from development laboratory or from other manufacturing unit
  • Purchase of raw materials and packaging and labelling materials
  • Manufacture of pharmaceutical and medical devices
  • QP release

Preparation forms

Sterile and non-sterile manufacture of medicines and medical devices.

Our experience contributes to important international research

Through our social mandate, APL has built up a very strong ability to adapt medicines to individual needs, and this in turn has made us attractive to the research sector.

APL in the world

Our customers are based in Sweden, Europe and USA. Patients the world over use products manufactured by us for our customers.

Please let us hear from you!

For further information, or if you have any request, please contact us via email or telephone Ulf Skough, Marketing Manager: +46-10-447 96 23




Visiting adress:

Prismavägen 2, Kungens Kurva


+46 10 447 96 00


Other contact information

About APL

APL is one of the leading manufacturers of extemporaneous medicines in Europe. We are also one of the leading contract manufacturer within Life Science in Scandinavia and an established partner for services and products to pharmacies. APL has more than 30 years of experience and an annual turnover of about 150 M EUR. With our 591 employees and four production plants in Sweden, we have resources for developing, analysing and producing medicines. APL contributes to medicines that improve and save lives.


Read more